Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LQVTDSGLYRCVIYHPP

😃Good
Catalog No. T78025Cas No. 887255-16-5

LQVTDSGLYRCVIYHPP (LP17) is a TREM-1 (triggering receptor expressed on myeloid cells) inhibitory peptide that mitigates ischemia-induced infarction and neuronal damage. It can penetrate the brain and inhibit TREM-1 [1].

LQVTDSGLYRCVIYHPP

LQVTDSGLYRCVIYHPP

😃Good
Catalog No. T78025Cas No. 887255-16-5
LQVTDSGLYRCVIYHPP (LP17) is a TREM-1 (triggering receptor expressed on myeloid cells) inhibitory peptide that mitigates ischemia-induced infarction and neuronal damage. It can penetrate the brain and inhibit TREM-1 [1].
Pack SizePriceAvailabilityQuantity
1 mg$607-10 days
5 mg$1477-10 days
10 mg$2637-10 days
25 mg$4467-10 days
50 mg$6457-10 days
100 mg$8867-10 days
500 mg$1,7907-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LQVTDSGLYRCVIYHPP (LP17) is a TREM-1 (triggering receptor expressed on myeloid cells) inhibitory peptide that mitigates ischemia-induced infarction and neuronal damage. It can penetrate the brain and inhibit TREM-1 [1].
In vitro
Treatment with LQVTDSGLYRCVIYHPP (LP17) at concentrations of 1 or 10 µM for 24 hours significantly reduced the mRNA levels of pro-inflammatory cytokines and chemokines following reoxygenation. Additionally, it notably decreased the extracellular protein levels of IL-1β and IL-18 in an oxygen-glucose deprivation (OGD) model of microglial cells [1]. At a concentration of 10 µM and the same duration, LP17 was found to interact with the SYK enzyme in microglial cells [1].
In vivo
LP17 (0.5 or 1 mg/kg; intranasal; once daily for 3 days) attenuated ischemia-induced infarction and neuronal damage in mice [1].
Chemical Properties
Molecular Weight1961.24
FormulaC89H137N23O25S
Cas No.887255-16-5
Storage & Solubility Information
Storagekeep away from moisture | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy LQVTDSGLYRCVIYHPP | purchase LQVTDSGLYRCVIYHPP | LQVTDSGLYRCVIYHPP cost | order LQVTDSGLYRCVIYHPP | LQVTDSGLYRCVIYHPP chemical structure | LQVTDSGLYRCVIYHPP in vivo | LQVTDSGLYRCVIYHPP in vitro | LQVTDSGLYRCVIYHPP formula | LQVTDSGLYRCVIYHPP molecular weight